Benzo[b]thiophene-2-carboxamide, N-[2-[2-[[[4-(trifluoromethoxy)phenyl]sulfonyl]amino]ethoxy]ethyl]-, 1,1-dioxide manufacturers
- SCP1-IN-1
-
- $64.00
-
2026-07-27
- CAS:2764615-55-4
- Purity: 99.53%
- Supply Ability: 10g
|
| | Benzo[b]thiophene-2-carboxamide, N-[2-[2-[[[4-(trifluoromethoxy)phenyl]sulfonyl]amino]ethoxy]ethyl]-, 1,1-dioxide Basic information |
| | Benzo[b]thiophene-2-carboxamide, N-[2-[2-[[[4-(trifluoromethoxy)phenyl]sulfonyl]amino]ethoxy]ethyl]-, 1,1-dioxide Chemical Properties |
| density | 1.496±0.06 g/cm3(Predicted) | | pka | 10.05±0.50(Predicted) | | form | Solid | | color | White to off-white |
| | Benzo[b]thiophene-2-carboxamide, N-[2-[2-[[[4-(trifluoromethoxy)phenyl]sulfonyl]amino]ethoxy]ethyl]-, 1,1-dioxide Usage And Synthesis |
| Uses | SCP1-IN-1 (compound SH T-62) is a potent and selective covalent inhibitor against SCP1. SCP1-IN-1 promotes REST degradation and reduces transcriptional activity. A high level of REST protein drives the tumor growth in some glioblastoma cells. SCP1-IN-1 has the potential for the research of glioblastoma whose growth is driven by REST transcription activity[1]. | | References | [1] Medellin B, et al. Targeted Covalent Inhibition of Small CTD Phosphatase 1 to Promote the Degradation of the REST Transcription Factor in Human Cells. J Med Chem. 2022;65(1):507-519. DOI:10.1021/acs.jmedchem.1c01655 |
| | Benzo[b]thiophene-2-carboxamide, N-[2-[2-[[[4-(trifluoromethoxy)phenyl]sulfonyl]amino]ethoxy]ethyl]-, 1,1-dioxide Preparation Products And Raw materials |
|